National guidelines for diagnosis and treatment of prostate cancer 2022 in China(English version)  

作　　者：无 Yong Yang 

机构地区：[1]National Health Commission of the People’s Republic of China [2]Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Peking University Cancer Hospital&Institute

出　　处：《Chinese Journal of Cancer Research》2022年第3期270-288,共19页中国癌症研究（英文版）

摘　　要：Contents 1.Overview 2.Etiology 2.1 Age and genetic factors 2.2 Exogenous factors 3.Pathological classification and grading system 3.1 Pathological grading and grouping of prostate cancer 3.2 Staging of prostate cancer 3.3 Risk grouping for patients with local or locally advanced prostate cancer 4.Diagnostic evaluation 4.1 Monitoring,screening and early diagnosis 4.2 Genetic testing。

关 键 词：DIAGNOSIS CANCER TREATMENT 

分 类 号：R737.25[医药卫生—肿瘤]